Immediate Impact

3 from Science/Nature 52 standout
Sub-graph 1 of 25

Citing Papers

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
2024 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
2 intermediate papers

Works of Jan B. Ruit being referenced

Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study
2006
Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre
2005

Author Peers

Author Last Decade Papers Cites
Jan B. Ruit 142 14 19 64 38 6 198
C. Tyler Kirkland 109 8 44 85 52 6 285
W. Messersmith 203 8 53 95 87 9 298
Hin‐Peng Lee 112 3 5 42 46 7 290
Erdogan Batman 85 25 56 33 29 8 192
A. Broxson 89 13 3 99 76 6 250
Alexandra Meuter 78 7 3 133 18 5 180
Anne-Sophie Dieudonné 129 21 55 26 39 11 253
Ionel Mitrica 67 19 30 59 41 12 156
Amalia S. Lehmann 113 8 47 114 70 9 299
Mohammad H. Saleh 94 39 14 118 16 6 294

All Works

Loading papers...

Rankless by CCL
2026